Skip to content
healthcare.dev
Get a free key

OMLYCLO

NDC 72606-035, omalizumab-igec, injection, from CELLTRION USA, Inc..

Product NDC
72606-035
Status
Listed
Labeler
CELLTRION USA, Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761399
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72606-035 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OMALIZUMAB75 mg/.5mL

Pharmacologic classes

Anti-IgE [EPC]; Decreased IgE Activity [PE]; IgE-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
72606-035-01726060035011 SYRINGE, GLASS in 1 CARTON (72606-035-01) / .5 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dbd8709f-1636-45d9-ba94-5a3bc5f22f84

Use it

Look up 72606-035 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72606-035 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72606-035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.